Lapatinib Interactions
There are 637 drugs known to interact with lapatinib, along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 123 are major, 500 are moderate, and 14 are minor.
- View all 637 medications that may interact with lapatinib
- View lapatinib alcohol/food interactions (2)
- View lapatinib disease interactions (9)
Most frequently checked interactions
View interaction reports for lapatinib and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Adrenalin (epinephrine)
- Adriamycin (doxorubicin)
- Albumin-ZLB (albumin human)
- Alka-Seltzer Original (aspirin/citric acid/sodium bicarbonate)
- Aloxi (palonosetron)
- Alupent (metaproterenol)
- AndroGel (testosterone)
- Arimidex (anastrozole)
- ASA-Free (trolamine salicylate topical)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- Eligard (leuprolide)
- Herceptin (trastuzumab)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Metoprolol Succinate ER (metoprolol)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
Lapatinib alcohol/food interactions
There are 2 alcohol/food interactions with lapatinib.
Lapatinib disease interactions
There are 9 disease interactions with lapatinib which include:
- cardiomyopathy
- dermatologic toxicities
- pulmonary toxicity
- QT prolongation
- pulmonary toxicity
- liver dysfunction
- CHF
- thrombocytopenia
- renal impairment
Report options
More about lapatinib
- lapatinib consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
